deaths from tirzepatide Treatment with #tirzepatide in the SUMMIT trial led to a lower risk of death cardiovascular causes or worsening heart failure and improved health status in patients with #HFpEF and obesity. https://t.co/O9iU9a1Xgw Tirzepatide for reduction of morbidity
Description
This reduces the burden on the digestive system
The compound activates the GIP receptor (glucose-dependent insulinotropic polypeptide), the GLP-1 receptor (glucagon-like peptide-1), and the glucagon receptor simultaneously [1]
Haarika Korlipara JC, Buckholz A, Jamison J, Gonzalez A, Kumar S, Weber M, Salgado S, Sharaiha R, Newberry C
In type 2 diabetes, the muscles, liver and other insulin-dependent tissues lose sensitivity to insulin and glucose remains in the blood and urine
Eur Urol 71 (2): 151-154, 2017
How does NuraPatch work
